Legacy web forms used for clinical trial recruitment, adverse event reporting, laboratory data collection, and regulatory ...

On April 9, 2026, Oxford BioTherapeutics announced a multi-year collaboration with Bristol Myers Squibb focused on the discovery and development of T-cell engager therapies for solid tumors. 1 ...

Digital twins function as synchronized, real-time operational mirrors, where divergence from the physical process triggers ...

VP of operations and support at Kiteworks, with more than 20 years of experience in IT support and services. Since joining ...

This article highlights how quality control microbiology is evolving into a proactive, integrated component of modern contamination control strategies across the biopharmaceutical lifecycle.

Indirect data suggest oral semaglutide outperforms orforglipron on weight loss and tolerability, with patients also favoring its treatment profile.

The FDA approved the first generic dapagliflozin tablets, opening a competitive US market for pharma manufacturers and ...

In part 2 of a 2-part interview,Susan Schniepp, Regulatory Compliance Associates Inc., discusses the evolving relationship ...

Digital predictive modeling is being used to simulate extreme distribution conditions and prioritize mitigation, but hybrid ...

Lilly licenses Insilico's AI drug discovery platform in a deal worth up to $2.75B, signaling a shift in how novel ...

Biocon launches two FDA-approved interchangeable denosumab biosimilars in the US, targeting osteoporosis and bone metastasis in a $5B market.

In part 3 of a 3-part interview, Susan Schniepp, Regulatory Compliance Associates Inc., makes a candid argument maintaining a ...